Literature DB >> 7936588

Oral candidiasis. History, classification, and clinical presentation.

D P Lynch1.   

Abstract

Candida albicans is a ubiquitous, dimorphous yeast; it has been known for many centuries, and has the potential to cause human disease under specific circumstances and conditions. The actual taxonomy of Candida albicans and related species has only been confirmed within the twentieth century. The oral carriage rate for the organism is high, with nearly one half of the healthy population harboring the organism. Numerous predisposing factors for oral candidiasis have been recognized, including metabolic, dietary, mechanical, and iatrogenic factors. Multiple clinical forms of the disease have been described, including acute, chronic, and mucocutaneous presentations. Although rarely fatal in the absence of other serious underlying disease, oral candidiasis may serve as a useful clinical marker for the presence of significant predisposing conditions.

Entities:  

Mesh:

Year:  1994        PMID: 7936588     DOI: 10.1016/0030-4220(94)90146-5

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol        ISSN: 0030-4220


  17 in total

1.  Candida albicans β-Glucan-Containing Particles Increase HO-1 Expression in Oral Keratinocytes via a Reactive Oxygen Species/p38 Mitogen-Activated Protein Kinase/Nrf2 Pathway.

Authors:  Yoko Ishida; Kouji Ohta; Takako Naruse; Hiroki Kato; Akiko Fukui; Hideo Shigeishi; Hiromi Nishi; Kei Tobiume; Masaaki Takechi
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

2.  Intercellular adhesion molecule 1-dependent activation of interleukin 8 expression in Candida albicans-infected human gingival epithelial cells.

Authors:  Hiroshi Egusa; Hiroki Nikawa; Seicho Makihira; Anahid Jewett; Hirofumi Yatani; Taizo Hamada
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  Invasive phenotype of Candida albicans affects the host proinflammatory response to infection.

Authors:  C C Villar; H Kashleva; A P Mitchell; A Dongari-Bagtzoglou
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

4.  PCR fingerprinting of Candida albicans associated with chronic hyperplastic candidosis and other oral conditions.

Authors:  K L Bartie; D W Williams; M J Wilson; A J Potts; M A Lewis
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

5.  Candida albicans Cannot Acquire Sufficient Ethanolamine from the Host To Support Virulence in the Absence of De Novo Phosphatidylethanolamine Synthesis.

Authors:  Sarah E Davis; Robert N Tams; Norma V Solis; Andrew S Wagner; Tian Chen; Joseph W Jackson; Sahar Hasim; Anthony E Montedonico; Justin Dinsmore; Timothy E Sparer; Scott G Filler; Todd B Reynolds
Journal:  Infect Immun       Date:  2018-07-23       Impact factor: 3.441

6.  Evolution of the complex transcription network controlling biofilm formation in Candida species.

Authors:  Eugenio Mancera; Isabel Nocedal; Stephen Hammel; Megha Gulati; Kaitlin F Mitchell; David R Andes; Clarissa J Nobile; Geraldine Butler; Alexander D Johnson
Journal:  Elife       Date:  2021-04-07       Impact factor: 8.140

7.  A comparative study of oral candidal species carriage in patients with type1 and type2 diabetes mellitus.

Authors:  Mangesh P Shenoy; Rudrayya S Puranik; Shrinivas S Vanaki; Surekha R Puranik; Pushparaja Shetty; Radhika Shenoy
Journal:  J Oral Maxillofac Pathol       Date:  2014-09

Review 8.  Candida is a protractive factor of chronic oral ulcers among usual outpatients.

Authors:  Haruhiko Terai; Takaaki Ueno; Yoshifumi Suwa; Michi Omori; Kayoko Yamamoto; Shin Kasuya
Journal:  Jpn Dent Sci Rev       Date:  2018-01-12

9.  Oral Candida spp carriers: its prevalence in patients with type 2 diabetes mellitus.

Authors:  Ramon Felipe Fernandez Martinez; Alejandra Jaimes-Aveldañez; Francisco Hernández-Pérez; Roberto Arenas; Guadalupe Fabián-San Miguel
Journal:  An Bras Dermatol       Date:  2013 Mar-Apr       Impact factor: 1.896

10.  Oral candidiasis: A retrospective study of 276 Brazilian patients.

Authors:  Henrique Cortes Meira; Bruna Mascarenhas De Oliveira; Igor Figueiredo Pereira; Marcelo Drumond Naves; Ricardo Alves Mesquita; Vagner Rodrigues Santos
Journal:  J Oral Maxillofac Pathol       Date:  2017 Sep-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.